The CADRE Summit: Growing Evidence Supports Role of Chromium in Prevention, Treatment of Diabetes

The trace element chromium, and particularly chromium picolinate, will likely find a greater role in the management of insulin resistance and Type 2 diabetes (T2D) in the coming years, as clinical evidence accumulates to support its antiglycemic, insulin-sensitizing effects. Chromium researchers from across the globe recently gathered to share their findings at a summit sponsored by the Council for the Advancement of Diabetes Research and Education (CADRE).

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.
Subscribe to Holistic Primary Care